Document Detail


Heat-sensitive liposomes containing cisplatin and localized hyperthermia in treatment of murine tumor.
MedLine Citation:
PMID:  9834620     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Combined therapy with heat-sensitive liposomes as carriers for drugs and local hyperthermia is thought to improve the local control rate. I studied the antitumor effects and concentrations of CDDP encapsulated in heat-sensitive liposomes (LIP-CDDP) in vivo. LIP-CDDP or CDDP-solution was given to 8 week-old male C3H/He mice bearing SCC VII tumors by tail vein injection, and tumors were heated at 40 degrees C or 42 degrees C. The concentration of LIP-CDDP in blood was significantly higher than that of CDDP-solution. The concentration in tumors after heating at 42 degrees C increased with heating time, but the concentration in tumors without heating or after heating at 40 degrees C did not show these changes. After heating at 42 degrees C, antitumor effects of LIP-CDDP were significantly better than those obtained with the use of CDDP-solution. Heating at 40 degrees C did not alter the antitumor effect of LIP-CDDP. Therefore, LIP-CDDP proved to be very effective when combined with local hyperthermia at 42 degrees C.
Authors:
T Nishita
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Osaka city medical journal     Volume:  44     ISSN:  0030-6096     ISO Abbreviation:  Osaka City Med J     Publication Date:  1998 Jun 
Date Detail:
Created Date:  1998-12-29     Completed Date:  1998-12-29     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0376413     Medline TA:  Osaka City Med J     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  73-83     Citation Subset:  IM    
Affiliation:
Department of Radiology, Osaka City University Medical School, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / administration & dosage*,  therapeutic use
Carcinoma, Squamous Cell / therapy*
Cisplatin / administration & dosage*,  therapeutic use
Drug Carriers
Hot Temperature*
Hyperthermia, Induced*
Liposomes*
Male
Mice
Mice, Inbred C3H
Neoplasms, Experimental / therapy
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Drug Carriers; 0/Liposomes; 15663-27-1/Cisplatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data.
Next Document:  Identification of the granulocyte colony-stimulating factor (G-CSF) producing cell population in hum...